Finance

Lists
Why is MRKR up 3,35%?
Dive Deeper
MRKR:NASDAQ
Marker Therapeutics Inc
0,92 USD
+3,35%
(+0,030) 1D
0,98 USD
+6,41% (+0,059)
After hours
Closed: 15-окт., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MRKR...
Open
0,96 USD
High
0,96 USD
Low
0,88 USD
Mkt. cap
15,42 млн
Avg. vol.
78,61 миң
Volume
120,79 миң
52-wk high
2,46 USD
52-wk low
0,84 USD
EPS
-0,47 USD
Beta
1,53
Shares outstanding
16,67 млн
No. of employees
5
Open
0,96 USD
High
0,96 USD
Low
0,88 USD
Mkt. cap
15,42 млн
Avg. vol.
78,61 миң
Volume
120,79 миң
52-wk high
2,46 USD
52-wk low
0,84 USD
EPS
-0,47 USD
Beta
1,53
Shares outstanding
16,67 млн
No. of employees
5
News stories
From web sources and news partners
About Marker Therapeutics Inc
CEO-
Employees5
Founded1992
HeadquartersХьюстон, Техас, Америка Кошмо Штаттары
Sector-
Websitemarkertherapeutics.com
Analyst ratings
Based on 2 analysts giving stock ratings to MRKR in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for MRKR in the last 3 months.
Highest
Current 0,92 USD
10,00 USD (+986,96%)
Average
9,00 USD (+878,26%)
Lowest
8,00 USD (+769,57%)
Analyst
Recommendation
Action
Price target
Projected
Date
Patrick Trucchio
H.C. Wainwright
Buy
Maintained
10,00 USD
+987%
09/21/2026
John Newman
Canaccord Genuity
Buy
Maintained
8,00 USD
+769,6%
08/17/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
1,23 млн
1,10 млн
751,69 миң
681,58 миң
Cost of goods sold
2,35 млн
2,14 млн
2,84 млн
1,48 млн
Cost of revenue
2,35 млн
2,14 млн
2,84 млн
1,48 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,02 млн
846,61 миң
1,23 млн
1,14 млн
Operating expense
1,02 млн
846,61 миң
1,23 млн
1,14 млн
Total operating expenses
3,37 млн
2,99 млн
4,07 млн
2,62 млн
Operating income
-2,14 млн
-1,88 млн
-4,07 млн
-2,62 млн
Other non operating income
-
-
760,37 миң
681,58 миң
EBT including unusual items
-2,00 млн
-1,72 млн
-3,18 млн
-1,83 млн
EBT excluding unusual items
-2,00 млн
-1,72 млн
-3,18 млн
-1,83 млн
Income tax expense
-
-15,16 миң
-
-
Effective tax rate
-
0,88%
-
-
Other operating expenses
-
-
-
-
Net income
-2,00 млн
-1,70 млн
-3,18 млн
-1,83 млн
Net profit margin
-162,11%
-154,35%
-
-
Earnings per share
-0,12
-0,04
-0,16
-0,09
Interest and investment income
138,06 миң
165,63 миң
132,89 миң
112,56 миң
Interest expense
-
-
-
-
Net interest expenses
138,06 миң
165,63 миң
132,89 миң
112,56 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору